Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 299

1.

Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma.

Xu XS, Qu K, Liu C, Zhang YL, Liu J, Song YZ, Zhang P, Liu SN, Chang HL.

World J Gastroenterol. 2012 Dec 28;18(48):7242-50. doi: 10.3748/wjg.v18.i48.7242.

PMID:
23326129
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival.

Riaz A, Ryu RK, Kulik LM, Mulcahy MF, Lewandowski RJ, Minocha J, Ibrahim SM, Sato KT, Baker T, Miller FH, Newman S, Omary R, Abecassis M, Benson AB 3rd, Salem R.

J Clin Oncol. 2009 Dec 1;27(34):5734-42. doi: 10.1200/JCO.2009.23.1282. Epub 2009 Oct 5.

PMID:
19805671
[PubMed - indexed for MEDLINE]
Free Article
3.

Impact of locoregional therapy and alpha-fetoprotein on outcomes in transplantation for liver cancer: a UNOS Region 6 pooled analysis.

Wong LL, Naugler WE, Schwartz J, Scott DL, Bhattacharya R, Reyes J, Orloff SL.

Clin Transplant. 2013 Jan-Feb;27(1):E72-9. doi: 10.1111/ctr.12056. Epub 2012 Dec 30.

PMID:
23278701
[PubMed - indexed for MEDLINE]
4.

Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein.

Nouso K, Kobayashi Y, Nakamura S, Kobayashi S, Takayama H, Toshimori J, Kuwaki K, Hagihara H, Onishi H, Miyake Y, Ikeda F, Shiraha H, Takaki A, Iwasaki Y, Kobashi H, Yamamoto K.

J Gastroenterol Hepatol. 2011 Jul;26(7):1195-200. doi: 10.1111/j.1440-1746.2011.06720.x.

PMID:
21410750
[PubMed - indexed for MEDLINE]
5.

Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization.

Lee YK, Kim SU, Kim do Y, Ahn SH, Lee KH, Lee do Y, Han KH, Chon CY, Park JY.

BMC Cancer. 2013 Jan 3;13:5. doi: 10.1186/1471-2407-13-5.

PMID:
23282286
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma.

Personeni N, Bozzarelli S, Pressiani T, Rimassa L, Tronconi MC, Sclafani F, Carnaghi C, Pedicini V, Giordano L, Santoro A.

J Hepatol. 2012 Jul;57(1):101-7. doi: 10.1016/j.jhep.2012.02.016. Epub 2012 Mar 10.

PMID:
22414760
[PubMed - indexed for MEDLINE]
7.

Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma.

Weis S, Franke A, Mössner J, Jakobsen JC, Schoppmeyer K.

Cochrane Database Syst Rev. 2013 Dec 19;12:CD003046. doi: 10.1002/14651858.CD003046.pub3. Review.

PMID:
24357457
[PubMed - indexed for MEDLINE]
8.

Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.

Wang Y, Chen Y, Ge N, Zhang L, Xie X, Zhang J, Chen R, Wang Y, Zhang B, Xia J, Gan Y, Ren Z, Ye S.

Ann Surg Oncol. 2012 Oct;19(11):3540-6. doi: 10.1245/s10434-012-2368-5. Epub 2012 Apr 25.

PMID:
22532305
[PubMed - indexed for MEDLINE]
9.

New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy.

Chan SL, Mo FK, Johnson PJ, Hui EP, Ma BB, Ho WM, Lam KC, Chan AT, Mok TS, Yeo W.

J Clin Oncol. 2009 Jan 20;27(3):446-52. doi: 10.1200/JCO.2008.18.8151. Epub 2008 Dec 8.

PMID:
19064965
[PubMed - indexed for MEDLINE]
Free Article
10.

Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis.

Yi X, Yu S, Bao Y.

Clin Chim Acta. 2013 Oct 21;425:212-20. doi: 10.1016/j.cca.2013.08.005. Epub 2013 Aug 13. Review.

PMID:
23954771
[PubMed - indexed for MEDLINE]
11.

Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part II. Response stratification using volumetric functional criteria after intraarterial therapy.

Bonekamp S, Halappa VG, Geschwind JF, Li Z, Corona-Villalobos CP, Reyes D, Bhagat N, Cosgrove DP, Pawlik TM, Mezey E, Eng J, Kamel IR.

Radiology. 2013 Aug;268(2):431-9. doi: 10.1148/radiol.13121637. Epub 2013 Apr 24.

PMID:
23616632
[PubMed - indexed for MEDLINE]
12.

A prognostic model for patients with hepatocellular carcinoma within the Milan criteria undergoing non-transplant therapies, based on 1106 patients.

Lee YH, Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Chiou YY, Huo TI.

Aliment Pharmacol Ther. 2012 Sep;36(6):551-9. doi: 10.1111/j.1365-2036.2012.05226.x. Epub 2012 Jul 22.

PMID:
22817677
[PubMed - indexed for MEDLINE]
13.

Serum alpha-fetoprotein level independently predicts posttransplant survival in patients with hepatocellular carcinoma.

Berry K, Ioannou GN.

Liver Transpl. 2013 Jun;19(6):634-45. doi: 10.1002/lt.23652.

PMID:
23536495
[PubMed - indexed for MEDLINE]
15.

Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.

Huo TI, Huang YH, Lui WY, Wu JC, Lee PC, Chang FY, Lee SD.

Oncol Rep. 2004 Feb;11(2):543-50.

PMID:
14719097
[PubMed - indexed for MEDLINE]
16.

Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.

Ni JY, Liu SS, Xu LF, Sun HL, Chen YT.

World J Gastroenterol. 2013 Jun 28;19(24):3872-82. doi: 10.3748/wjg.v19.i24.3872.

PMID:
23840128
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma.

Shao YY, Lin ZZ, Hsu C, Shen YC, Hsu CH, Cheng AL.

Cancer. 2010 Oct 1;116(19):4590-6. doi: 10.1002/cncr.25257.

PMID:
20572033
[PubMed - indexed for MEDLINE]
Free Article
18.

Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy.

Huo TI, Hsu CY, Huang YH, Su CW, Lin HC, Lee RC, Chiou YY, Chiang JH, Lee PC, Lee SD.

BMC Gastroenterol. 2010 Dec 31;10:146. doi: 10.1186/1471-230X-10-146.

PMID:
21194431
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.

Yang WS, Va P, Bray F, Gao S, Gao J, Li HL, Xiang YB.

PLoS One. 2011;6(12):e27326. doi: 10.1371/journal.pone.0027326. Epub 2011 Dec 21.

PMID:
22205924
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis.

Shim JH, Yoon DL, Han S, Lee YJ, Lee SG, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS.

Ann Surg Oncol. 2012 Nov;19(12):3687-96. doi: 10.1245/s10434-012-2416-1. Epub 2012 May 30.

PMID:
22644512
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk